BUSINESS | PRESS RELEASES – The Providence Journal

BUSINESS | PRESS RELEASES
The Providence Journal
Surveyed U.S. and European pulmonologists agree that reduction in rate of exacerbations is the attribute that most influences prescribing decisions in moderate to severe asthma. Clinical data and the opinions of interviewed thought leaders indicate
For Severe Asthma, Most Surveyed U.S. Payers Would Reimburse a Novel MarketWatch

all 3 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.